ANXA2 and esophageal squamous cell carcinoma: In the esophagus, despite the limited existing research, ANXA2 has been shown to activate the MYC-HIF-1A-VEGF signaling in ESCC cells, a pathway whose inhibition suppresses the growth of ESCC xenograft tumors in mice [64].